Stock listing
NASDAQ:KDMN Kadmon Holdings Inc Stock
Follow Kadmon Holdings Inc into a list and get an email when it puts out news.
Last close · NASDAQ:KDMN
$9.50 USD
Close on Nov 9, 2021 · No longer trades
- Lowest – highest close
- $1.65 – $10.23 USDSince Jul 27, 2016 · lowest Jun 25, 2019 · highest Aug 16, 2016
Delisted NASDAQ:KDMN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:KDMN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Kadmon Holdings Inc on 6ix
- Decks
- 6 decks · latest Dec 7, 2020
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (December 2020) | Technical | 18 slides | Dec 7, 2020 |
| Technical Presentation (May 2020) | Technical | 23 slides | May 21, 2020 |
| Technical Presentation (November 2019) | Technical | 16 slides | Nov 13, 2019 |
| Investor Presentation (June 2018) | Investor deck | 25 slides | Jun 11, 2018 |
| Investor Presentation (September 2017) | Investor deck | 26 slides | Sep 25, 2017 |
| Investor Presentation (March 2017) | Investor deck | 34 slides | Mar 8, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Konstantin Poukalov Other companies: ARYA Sciences Acquisition Corp V (Chief Business Officer · Jul 12, 2021 – Jul 12, 2021 · Past); ARYA Sciences Acquisition IV Corp (Chief Business Officer · Feb 25, 2021 – Jul 31, 2024 · Past); Landos Biopharma Inc (Director · Feb 3, 2021 – Feb 8, 2021 · Past); Nautilus Biotechnology, Inc. (Chief Business Officer · Aug 6, 2020 – Aug 6, 2020 · Past); Cerevel Therapeutics Holdings Inc (Chief Business Officer · Jun 4, 2020 – Jun 4, 2020 · Past); Lyra Therapeutics, Inc. (Director · Apr 30, 2020 – Jun 13, 2024 · Past) | Executive Vice President, CFO · Jul 26, 2016 – Dec 8, 2017 · Past |
| Eugene Bauer Other companies: Evommune, Inc. (Executive Director, Chief Medical Officer · Since at least Nov 5, 2025); Applied UV, Inc. (Director · Aug 28, 2020 – Dec 31, 2021 · Past); Avalo Therapeutics, Inc. (Director · Oct 14, 2015 – Mar 31, 2018 · Past); Aevi Genomic Medicine LLC (Director · Apr 7, 2011 – Feb 3, 2020 · Past); Connetics Corp (Director · Dec 30, 2005 – Dec 30, 2005 · Past) | Director · May 15, 2019 – Nov 9, 2021 · Past |
| Arthur Kirsch Other companies: Evommune, Inc. (Audit · Since at least Nov 5, 2025); Atea Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Liquidia Corporation (Board Member · Since at least Mar 24, 2021); Aralez Pharmaceuticals Inc (Director · May 12, 2016 – Dec 8, 2017 · Past) | Director · May 15, 2019 – Nov 9, 2021 · Past |
| Tasos Konidaris Other companies: Amneal Pharmaceuticals, Inc. (Executive Vice President, Chief Financial Officer · Since at least Mar 12, 2020); Pernix Therapeutics Holdings Inc (Director · Apr 25, 2014 – May 26, 2016 · Past); Delcath Systems, Inc. (Director · Jul 5, 2012 – Jul 7, 2014 · Past); Dun & Bradstreet Holdings Inc. (SVP, Chief Financial Officer · Feb 9, 2006 – Mar 16, 2011 · Past) | Director · Feb 15, 2017 – Nov 9, 2021 · Past |
| David E. Cohen Other companies: Evommune, Inc. (Compensation · Since at least Nov 5, 2025); Timber Pharmaceuticals Inc (Director · Aug 19, 2020 – Apr 15, 2023 · Past); Connetics Corp (Director · May 22, 2006 – Dec 29, 2006 · Past) | Director · Feb 6, 2019 – Nov 9, 2021 · Past |
| Gregory S. Moss Other companies: Evommune, Inc. (Chief Business and Legal Officer · Since at least Nov 5, 2025); Anteris Technologies Global Corp. (Director · Since at least Jun 7, 2025); MeiraGTx Holdings plc (Director · Jun 8, 2018 – Jun 8, 2018 · Past) | EVP, Gen. Coun. / CCO. · Aug 30, 2019 – Nov 9, 2021 · Past |
| Nancy Miller-Rich Other companies: 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); Aldeyra Therapeutics, Inc. (Director · Since at least Jan 13, 2020); Intercept Pharmaceuticals Inc (Director · Apr 24, 2018 – Nov 8, 2023 · Past) | Director · Aug 13, 2020 – Nov 9, 2021 · Past |
| Cynthia L. Flowers Other companies: Lisata Therapeutics, Inc. (Director · Since at least Nov 7, 2018); G1 Therapeutics Inc (Director · Jun 7, 2018 – Sep 18, 2024 · Past) | Director · Jan 22, 2019 – Nov 8, 2021 · Past |
| Harlan Waksal Other companies: Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past); Lyra Therapeutics, Inc. (Executive Chair, Director · Feb 16, 2022 – Dec 9, 2024 · Past) | President, CEO, Director · Jul 26, 2016 – Nov 9, 2021 · Past |
| Thomas E. Shenk Other companies: MeiraGTx Holdings plc (Independent Board Member · Since at least Jun 8, 2018); Vical Incorporated (Director · Dec 18, 2015 – May 23, 2018 · Past) | Director · Jul 26, 2016 – Jun 29, 2017 · Past |
All 23 people
| Person | Seat |
|---|---|
| Alexandria Forbes Other companies: MeiraGTx Holdings plc (Board Member, President and Chief Executive Officer · Since at least Jun 8, 2018) | Director · Jul 26, 2016 – Jun 29, 2017 · Past |
| Andrew B Cohen Other companies: Laureate Education, Inc. (Director · Since at least Dec 8, 2020) | Director · Jul 26, 2016 – Dec 15, 2016 · Past |
| Bart M Schwartz Other companies: HMS Holdings Corp (Director · Jul 29, 2010 – Mar 31, 2021 · Past) | Director · Jul 26, 2016 – Jul 27, 2018 · Past |
| John L Ryan Other companies: Unicycive Therapeutics, Inc. (Director · Jul 12, 2021 – Sep 5, 2023 · Past) | EVP, Chief Medical Officer · Jul 26, 2016 – Nov 9, 2021 · Past |
| Kyle Carver Other companies: Evommune, Inc. (Chief Financial Officer · Since at least Nov 5, 2025) | SVP, CAO, Controller · Oct 24, 2018 – Nov 9, 2021 · Past |
| Lawrence Kenneth Cohen Other companies: Via Pharmaceuticals Inc (CEO and President, Director · Aug 2, 2007 – Dec 17, 2008 · Past) | Exec. VP, Business Develop. · Jul 26, 2016 – Dec 15, 2016 · Past |
| Steven Meehan Other companies: Twenty One Capital, Inc. (Chief Financial Officer · Since at least Dec 8, 2025) | EVP, Chief Financial Officer · Jan 17, 2017 – Nov 9, 2021 · Past |
| Charles Darder | Principle Accounting Officer · Jul 26, 2016 – Dec 8, 2017 · Past |
| D Dixon Boardman | Director · Jul 26, 2016 – May 15, 2019 · Past |
| Larry Witte | Exec. VP, Research & Develop. · Jul 26, 2016 – Jul 26, 2016 · Past |
| Steven N Gordon | Exec VP, GC, Chief Admin, Comp · Jul 26, 2016 – Jun 14, 2019 · Past |
| Susan Wiviott | Director · Jul 26, 2016 – Jul 27, 2018 · Past |
| Zhenping Zhu | Executive VP Biologics · Jul 26, 2016 – Jul 26, 2016 · Past |
Log in to ask 6ix AI your own questions about Kadmon Holdings Inc.